Finding 4453 (2022-001)

Material Weakness Repeat Finding
Requirement
L
Questioned Costs
-
Year
2022
Accepted
2023-12-15

AI Summary

  • Core Issue: Management's capability to accurately prepare financial statements and the SEFA is in question.
  • Impacted Requirements: Compliance with financial reporting standards and federal regulations may be at risk.
  • Recommended Follow-Up: Conduct a review of management's processes and controls for drafting financial documents.

Finding Text

Consideration of Management’s Ability to Draft the Financial Statements, Schedule of Expenditures of Federal Awards (“SEFA”) and Related Footnotes

Corrective Action Plan

VARR agrees with the finding and will continue to enhance our knowledge and understanding of financial reporting, knowing that due to the small size and limited financial resources obtaining a qualified accounting professional either as an employee or an outside consultant to the level of skills, knowledge and experience necessary may be difficult. Effective November 27, 2023, VARR’s management and executive director is taking remedial steps to become better acquainted with the matters and items contained in its financial statements that may allow VARR to prepare its financial statements in an acceptable manner to its independent auditor by January 31, 2024. This action is in accordance with the requirements of Uniform Guidance 2 CFR §200.511(c).

Categories

Reporting

Other Findings in this Audit

  • 4454 2022-002
    Material Weakness Repeat
  • 4455 2022-003
    Material Weakness Repeat
  • 4456 2022-001
    Material Weakness Repeat
  • 4457 2022-002
    Material Weakness Repeat
  • 4458 2022-003
    Material Weakness Repeat
  • 4459 2022-001
    Material Weakness Repeat
  • 4460 2022-002
    Material Weakness Repeat
  • 4461 2022-003
    Material Weakness Repeat
  • 4462 2022-001
    Material Weakness Repeat
  • 4463 2022-002
    Material Weakness Repeat
  • 4464 2022-003
    Material Weakness Repeat
  • 4465 2022-001
    Material Weakness Repeat
  • 4466 2022-002
    Material Weakness Repeat
  • 4467 2022-003
    Material Weakness Repeat
  • 4468 2022-001
    Material Weakness
  • 4469 2022-002
    Material Weakness
  • 4470 2022-003
    Material Weakness
  • 580895 2022-001
    Material Weakness Repeat
  • 580896 2022-002
    Material Weakness Repeat
  • 580897 2022-003
    Material Weakness Repeat
  • 580898 2022-001
    Material Weakness Repeat
  • 580899 2022-002
    Material Weakness Repeat
  • 580900 2022-003
    Material Weakness Repeat
  • 580901 2022-001
    Material Weakness Repeat
  • 580902 2022-002
    Material Weakness Repeat
  • 580903 2022-003
    Material Weakness Repeat
  • 580904 2022-001
    Material Weakness Repeat
  • 580905 2022-002
    Material Weakness Repeat
  • 580906 2022-003
    Material Weakness Repeat
  • 580907 2022-001
    Material Weakness Repeat
  • 580908 2022-002
    Material Weakness Repeat
  • 580909 2022-003
    Material Weakness Repeat
  • 580910 2022-001
    Material Weakness
  • 580911 2022-002
    Material Weakness
  • 580912 2022-003
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
21.027 Coronavirus State and Local Fiscal Recovery Funds $1.12M
93.959 Block Grants for Prevention and Treatment of Substance Abuse $773,461
93.788 Opioid Str $34,410